Royalty Pharma plcRPRXNASDAQ
Loading
Debt to Equity Over TimeNormalizing
Percentile Rank80
3Y CAGR+3.0%
5Y CAGR+2.7%
Year-over-Year Change
Debt-to-equity ratio
3Y CAGR
+3.0%/yr
vs -3.4%/yr prior
5Y CAGR
+2.7%/yr
Consistent
Acceleration
+6.4pp
Accelerating
Percentile
P80
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
2 yr
Consecutive growthNormalizing
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 1.38 | +26.1% |
| 2024 | 1.10 | +16.6% |
| 2023 | 0.94 | -25.7% |
| 2022 | 1.26 | +2.9% |
| 2021 | 1.23 | +1.8% |
| 2020 | 1.21 | +18.1% |
| 2019 | 1.02 | -29.7% |
| 2018 | 1.45 | -4.7% |
| 2017 | 1.52 | +14.9% |
| 2016 | 1.33 | - |